![]() |
||||||||||||||||||||||||||||||
What are Dendrimers? Dendrimers are tree like macromolecules with branching reach out from central core. In late 1970s, scientists like Fritz Vögtle, at the University of Bonn, Germany, and Donald A. Tomalia, then working for Dow Chemical in Midland, Mich., started to build the first of these branching molecules. A keyword search for "dendrimers" and "dendritic polymers" shows that the number of dendrimer-related papers published has grown from a handful in the early 1990s to more than 1,000 research papers in 2005. These branched macromolecules are constructed around a simple core unit. dendrimers have a high degree of molecular uniformity, narrow molecular weight distribution, specific size and shape characteristics, and a highly- functionalized terminal surface. The manufacturing process is a series of repetitive steps starting with a central initiator core. Each subsequent growth step represents a new "generation" of polymer with a larger molecular diameter, twice the number of reactive surface sites, and approximately double the molecular weight of the preceding generation. |
||||||||||||||||||||||||||||||
Companies |
||||||||||||||||||||||||||||||
| Dendritic Nanotechnologies inc. Starpharma Ltd NanoCure Corp |
||||||||||||||||||||||||||||||
| Dendrimer Suppliers |
||||||||||||||||||||||||||||||
| Dendritic Nanotechnologies inc. Sigma-Aldrich Fisher Scientific |
||||||||||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Dendrimers attracted as nano carriers due to their size, possible encapsulation of drugs in the core of the dendrimer, and chemical conjugation of drugs, solubilizing groups (including polyoxyethylene glycol), and ligands to the surface of dendrimers making them ideal nanocarriers for drug delivery. Products based on dendrimers are get into market and Vivagel is the first product based on dendrimer which is under Phase I clinical Trial. Related Publications Enhanced porphyrin accumulation using dendritic derivatives of 5-aminolaevulinic acid for photodynamic therapy: An in vitro study.NEW International journal of biochemistry & cell biology, 2006, In Press Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention Molecular Pharmaceutics, 2005, 2, 312 -318. Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle Neoplasia. 2005, 7, 984-991 Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications Drug Discovery Today, 2001, 6, 427-436 Patent Watch One of the First Patents on Dendrimers Dense star polymers having core, core branches, terminal groups Tomalia Et al., USPT 4,507,466, March 26, 1985. Bioactive and/or targeted dendrimer conjugates Tomalia Et al., USPT 5,714,166 February 3, 1998. Phosphorus-containing dendrimers as transfection agents Majoral , et al. USPT 6,969,528 November 29, 2005 |
||||||||||||||||||||||||||||||
| About us | Advertising | Contact us © 2005-2006 NanoPharmaceuticals.org. All rights reserved. No part of this Internet site may be reproduced without prior written permission of the copyright holder. Terms & Disclaimer |
||||||||||||||||||||||||||||||
